These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1900428)
1. Follicle stimulating hormone levels as a predictor of recovery of spermatogenesis following cancer therapy. Kader HA; Rostom AY Clin Oncol (R Coll Radiol); 1991 Jan; 3(1):37-40. PubMed ID: 1900428 [TBL] [Abstract][Full Text] [Related]
2. [Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Kreuser ED; Kurrle E; Hetzel WD; Heymer B; Porzsolt F; Hautmann R; Gaus W; Schlipf U; Pfeiffer EF; Heimpel H Klin Wochenschr; 1989 Apr; 67(7):367-78. PubMed ID: 2501552 [TBL] [Abstract][Full Text] [Related]
3. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy. Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T J Androl; 2009; 30(3):280-6. PubMed ID: 19136393 [TBL] [Abstract][Full Text] [Related]
4. Fertility after high-dose chemotherapy for testicular cancer. Ishikawa T; Kamidono S; Fujisawa M Urology; 2004 Jan; 63(1):137-40. PubMed ID: 14751366 [TBL] [Abstract][Full Text] [Related]
5. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte. van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ; J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571 [TBL] [Abstract][Full Text] [Related]
6. [Spermato- and steroidogenesis in young men treated for non-Hodgkin's and Hodgkin's lymphoma during childhood]. Krawczuk-Rybak M; Solarz E; Gadomski J; Matysiak M; Wołczyński S Med Wieku Rozwoj; 2006; 10(3 Pt 1):623-30. PubMed ID: 17317893 [TBL] [Abstract][Full Text] [Related]
7. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149 [TBL] [Abstract][Full Text] [Related]
8. Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer. Fosså SD; Klepp O; Norman N Br J Urol; 1988 Nov; 62(5):449-53. PubMed ID: 2850071 [TBL] [Abstract][Full Text] [Related]
9. Testicular function following the treatment of Hodgkin's disease in childhood. Shafford EA; Kingston JE; Malpas JS; Plowman PN; Pritchard J; Savage MO; Eden OB Br J Cancer; 1993 Dec; 68(6):1199-204. PubMed ID: 8260374 [TBL] [Abstract][Full Text] [Related]
10. Treatment with the gonadotropin-releasinghormone agonist buserelin to protect spermatogenesis against cytotoxic treatment in young men. Krause W; Pflüger KH Andrologia; 1989; 21(3):265-70. PubMed ID: 2476046 [TBL] [Abstract][Full Text] [Related]
11. Testicular dysfunction in Hodgkin's disease before and after treatment. Viviani S; Ragni G; Santoro A; Perotti L; Caccamo E; Negretti E; Valagussa P; Bonadonna G Eur J Cancer; 1991; 27(11):1389-92. PubMed ID: 1835853 [TBL] [Abstract][Full Text] [Related]
12. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood. van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817 [TBL] [Abstract][Full Text] [Related]
13. Effects of taxane-based chemotherapy on inhibin B and gonadotropins as biomarkers of spermatogenesis. Chatzidarellis E; Makrilia N; Giza L; Georgiadis E; Alamara C; Syrigos KN Fertil Steril; 2010 Jul; 94(2):558-63. PubMed ID: 19765702 [TBL] [Abstract][Full Text] [Related]
14. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man. Van Thiel DH; Sherins RJ; Myers GH; De Vita VT J Clin Invest; 1972 Apr; 51(4):1009-19. PubMed ID: 4552337 [TBL] [Abstract][Full Text] [Related]
16. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005 [TBL] [Abstract][Full Text] [Related]
17. Testicular function following combination chemotherapy with cis-platin, vinblastine, and bleomycin. Johnson DH; Hainsworth JD; Linde RB; Greco FA Med Pediatr Oncol; 1984; 12(4):233-8. PubMed ID: 6205244 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related]
19. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Rueffer U; Breuer K; Josting A; Lathan B; Sieber M; Manzke O; Grotenhermen FJ; Tesch H; Bredenfeld H; Koch P; Nisters-Backes H; Wolf J; Engert A; Diehl V Ann Oncol; 2001 Sep; 12(9):1307-11. PubMed ID: 11697845 [TBL] [Abstract][Full Text] [Related]
20. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence. Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]